This effect demonstrated an L-NAME responsive, L-arginine responsive, opposite effect pattern, indicating bidirectional NO system modulation underlies BPC-157s anti-anhedonic action
It might push pigment deeper or cause pigment to move within the skin, creating an undesirable look (which is why it is not recommended)
The NNMT enzyme it inhibits is constitutively expressed in adipose tissue and liver, meaning timing relative to meals is less critical than consistency
It is studied in animal models for its reported effects on the nitric-oxide (NO) system, angiogenic signaling, and connective-tissue repair, and is supplied to qualified laboratories as a lyophilized reference peptide for benchtop research only
The FDA notice cites several possible medical uses for the substances, such as using BPC-157 to treat ulcerative colitis